Triplet‐Triplet Annihilation Upconversion‐Based Photolysis: Applications in Photopharmacology - Inria - Institut national de recherche en sciences et technologies du numérique Accéder directement au contenu
Article Dans Une Revue Advanced Healthcare Materials Année : 2024

Triplet‐Triplet Annihilation Upconversion‐Based Photolysis: Applications in Photopharmacology

Résumé

The emerging field of photopharmacology is a promising chemobiological methodology for optical control of drug activities that could ultimately solve the off-target toxicity outside the disease location of many drugs for the treatment of a given pathology. The use of photolytic reactions looks very attractive for a light-activated drug release but requires to develop photolytic reactions sensitive to red or near-infrared light excitation for better tissue penetration. This review will present the concepts of triplet-triplet annihilation upconversion-based photolysis and their recent in vivo applications for light-induced drug delivery using photoactivatable nanoparticles.

Domaines

Matériaux
Fichier principal
Vignette du fichier
islandora_170725.pdf (3.93 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04555407 , version 1 (22-04-2024)

Identifiants

Citer

Maxime Klimezak, Juliane Chaud, Anaïs Brion, Frédéric Bolze, Benoît Frisch, et al.. Triplet‐Triplet Annihilation Upconversion‐Based Photolysis: Applications in Photopharmacology. Advanced Healthcare Materials, 2024, in press, ⟨10.1002/adhm.202400354⟩. ⟨hal-04555407⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More